EMF vs NPCT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
EMF presents a compelling value opportunity, anchored by a stable Piotroski F-Score of 5/9 and a current price ($20.41) that sits significantly below both its Graham Number ($36.14) and Intrinsic Value ($99.12). The fund exhibits exceptional valuation metrics with a P/E of 6.07, far below the sector average, and a strong ROE of 20.84%. While revenue growth is currently negative (-13.30%), the massive surge in earnings growth (98.90%) and negligible debt (D/E 0.02) suggest high operational efficiency. Despite a bearish technical trend score, the fundamental disconnect between price and fair value provides a substantial margin of safety.
NPCT exhibits critical fundamental weakness, anchored by a Piotroski F-Score of 1/9, indicating severe financial instability. The fund is trading at a significant premium to its intrinsic value of $6.30, with a current price of $10.58. Most alarmingly, the dividend payout ratio of 146.56% suggests the 11.23% yield is unsustainable and likely funded by return of capital. Despite recent short-term price gains, the technical trend is rated as fully bearish (0/100).
Compare Another Pair
Related Comparisons
EMF vs NPCT: Head-to-Head Comparison
This page compares Templeton Emerging Markets Fund (EMF) and Nuveen Core Plus Impact Fund (NPCT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.